ISCB34 - 34th Annual Conference of the International Society for Clinical Biostatistics - Munich, 25-29 August 2013 34th Annual Conference of the International Society for Clinical Biostatistics, 25 - 29 August 2013 in Munich, Germany. An array of fascinating topics has been organized by the conference´s Scientific Programme Committee, including biomarker-based clinical trial designs, statistics for global clinical trials, and social networks in infectious diseases. This year´s customary Thursday Symposium will address topics related to individual prediction, personalized medicine, vaccination, and guidelines for prognostic research, which are sure to provide stimulating discussions and fuel for thoughts. 34th Annual Conference of the International Society for Clinical Biostatistics, 25 - 29 August 2013 in Munich, Germany. An array of fascinating topics has been organized by the conference´s Scientific Programme Committee, including biomarker-based clinical trial designs, statistics for global clinical trials, and social networks in infectious diseases. This year´s customary Thursday Symposium will address topics related to individual prediction, personalized medicine, vaccination, and guidelines for prognostic research, which are sure to provide stimulating discussions and fuel for thoughts. Clinical Biostatistics, ISCB34, https://cast.itunes.uni-muenchen.de/vod/playlists/basVjat5xZ.html Fri, 23 Aug 2013 07:47:44 +0000 Prof. Dr. rer. nat. Ulrich Mansmann Ludwig-Maximilians-Universität München itunes@lmu.de no en From model building to validation and back: a plea for robustness https://cast.itunes.uni-muenchen.de/clips/9ho1ldTyxk/vod/high_quality.mp4 ISCB 2013 ISCB 2013 Thu, 18 Apr 2019 16:58:59 +0000 Hans van Houwelingen ISCB 2013 no 00:57:12 2 https://cast.itunes.uni-muenchen.de/clips/9ho1ldTyxk/vod/high_quality.mp4 Recent developments in updating and extending risk prediction models, the Prostate Cancer Prevention Trial Calculator https://cast.itunes.uni-muenchen.de/clips/LR9L7VCGmv/vod/high_quality.mp4 contribution and discussion contribution and discussion Thu, 29 Aug 2013 17:37:30 +0000 Donna P. Ankerst, Technische Universitaet Muenchen and University of Texas Health Science Center at San Antonio ISCB 2013 no 00:47:43 3 https://cast.itunes.uni-muenchen.de/clips/LR9L7VCGmv/vod/high_quality.mp4 Recent developments in updating and extending risk prediction models, the European Randomized Study of Prostate Cancer Risk Calculator https://cast.itunes.uni-muenchen.de/clips/A4rVfFK5xU/vod/high_quality.mp4 ISCB 2013 ISCB 2013 Thu, 18 Apr 2019 17:11:59 +0000 Ewout Steyerberg, Erasmus University ISCB 2013 no 00:29:49 4 https://cast.itunes.uni-muenchen.de/clips/A4rVfFK5xU/vod/high_quality.mp4 Joint longitudinal survival models for prediction of prostate cancer recurrence following radiotherapy https://cast.itunes.uni-muenchen.de/clips/1HjzUdBHHH/vod/high_quality.mp4 ISCB 2013 ISCB 2013 Thu, 18 Apr 2019 16:56:03 +0000 Jeremy M.G. Taylor, University of Michigan ISCB 2013 no 00:23:45 5 https://cast.itunes.uni-muenchen.de/clips/1HjzUdBHHH/vod/high_quality.mp4 The meta-analytic approach to validation of surrogate endpoints https://cast.itunes.uni-muenchen.de/clips/jsNOeY66AW/vod/high_quality.mp4 ISCB 2013 ISCB 2013 Wed, 28 Aug 2013 18:00:14 +0000 Tomasz Burzykowski, Diepenbeek, Belgium ISCB 2013 no 00:22:15 6 https://cast.itunes.uni-muenchen.de/clips/jsNOeY66AW/vod/high_quality.mp4 TBD (on meta-regression) https://cast.itunes.uni-muenchen.de/clips/DkZcITds8R/vod/high_quality.mp4 ISCB 2013 ISCB 2013 Wed, 28 Aug 2013 17:47:45 +0000 Keith Abrams, Leicester, UK ISCB 2013 no 00:19:39 8 https://cast.itunes.uni-muenchen.de/clips/DkZcITds8R/vod/high_quality.mp4 Evaluating and addressing consistency of the evidence in a network metaanalysis https://cast.itunes.uni-muenchen.de/clips/fXE9M9TTVr/vod/high_quality.mp4 ISCB 2013 ISCB 2013 Thu, 18 Apr 2019 17:13:19 +0000 Julian Higgins, Bristol, UK ISCB 2013 no 00:19:03 9 https://cast.itunes.uni-muenchen.de/clips/fXE9M9TTVr/vod/high_quality.mp4 Assessing mediation through multiple pathways using natural effect models https://cast.itunes.uni-muenchen.de/clips/EHQEpBEWEo/vod/high_quality.mp4 ISCB 2013 ISCB 2013 Wed, 28 Aug 2013 18:30:17 +0000 Theis Lange, Copenhagen, Denmark ISCB 2013 no 00:23:07 10 https://cast.itunes.uni-muenchen.de/clips/EHQEpBEWEo/vod/high_quality.mp4 Causal search in high-dimensional settings https://cast.itunes.uni-muenchen.de/clips/Eo81evxGru/vod/high_quality.mp4 ISCB 2013 ISCB 2013 Thu, 29 Aug 2013 07:46:14 +0000 Marloes Maathuis, Zurich, Switzerland ISCB 2013 no 00:25:50 11 https://cast.itunes.uni-muenchen.de/clips/Eo81evxGru/vod/high_quality.mp4 Estimating effects of time-varying treatments: pitfalls and opportunities https://cast.itunes.uni-muenchen.de/clips/fhW2Z6Pin5/vod/high_quality.mp4 ISCB 2013 ISCB 2013 Thu, 18 Apr 2019 17:16:32 +0000 Marshal Joffee ISCB 2013 no 00:30:11 12 https://cast.itunes.uni-muenchen.de/clips/fhW2Z6Pin5/vod/high_quality.mp4 Using network meta-analysis for decision making https://cast.itunes.uni-muenchen.de/clips/CIUtxNAjD6/vod/high_quality.mp4 ISCB 2013 ISCB 2013 Thu, 18 Apr 2019 16:58:47 +0000 Sofia Dias, Bristol, UK ISCB 2013 no 00:22:30 13 https://cast.itunes.uni-muenchen.de/clips/CIUtxNAjD6/vod/high_quality.mp4 Purposeful penalization of likelihood in small samples https://cast.itunes.uni-muenchen.de/clips/BA9uUEFWbv/vod/high_quality.mp4 ISCB 2013 ISCB 2013 Tue, 27 Aug 2013 20:06:20 +0000 Georg Heinze, Vienna, Austria ISCB 2013 no 00:27:06 14 https://cast.itunes.uni-muenchen.de/clips/BA9uUEFWbv/vod/high_quality.mp4 Two folklores: ridge regression versus the lasso https://cast.itunes.uni-muenchen.de/clips/kJHi27ojXu/vod/high_quality.mp4 ISCB 2013 ISCB 2013 Tue, 27 Aug 2013 20:33:12 +0000 Jelle Goeman, Leiden, The Netherlands ISCB 2013 no 00:28:19 15 https://cast.itunes.uni-muenchen.de/clips/kJHi27ojXu/vod/high_quality.mp4 Penalization Theory and Practice for Cox Models https://cast.itunes.uni-muenchen.de/clips/nMRQwQEPxx/vod/high_quality.mp4 ISCB 2013 ISCB 2013 Thu, 18 Apr 2019 17:21:59 +0000 Terry Therneau, Minnesota, USA ISCB 2013 no 00:29:40 16 https://cast.itunes.uni-muenchen.de/clips/nMRQwQEPxx/vod/high_quality.mp4 Adaptive designs for confirmatory clinical trials with treatment selection https://cast.itunes.uni-muenchen.de/clips/K9tHPqQMrm/vod/high_quality.mp4 ISCB 2013 ISCB 2013 Thu, 18 Apr 2019 14:21:02 +0000 Nigel Stallard, Warwick Medical School, UK ISCB 2013 no 00:19:36 17 https://cast.itunes.uni-muenchen.de/clips/K9tHPqQMrm/vod/high_quality.mp4 Utility-Based Dose-Finding with Ordinal Toxicity and Efficacy https://cast.itunes.uni-muenchen.de/clips/oLDq7W287a/vod/high_quality.mp4 ISCB 2013 ISCB 2013 Thu, 29 Aug 2013 07:47:38 +0000 Peter F. Thall, Anderson Cancer Center, USA ISCB 2013 no 00:18:57 18 https://cast.itunes.uni-muenchen.de/clips/oLDq7W287a/vod/high_quality.mp4 Biomarker-based phase III clinical trial: Real-world experiences https://cast.itunes.uni-muenchen.de/clips/jh37Sdxpa0/vod/high_quality.mp4 ISCB 2013 ISCB 2013 Thu, 18 Apr 2019 17:21:23 +0000 Daniel Sargent, Mayo Clinic, USA ISCB 2013 no 00:23:02 20 https://cast.itunes.uni-muenchen.de/clips/jh37Sdxpa0/vod/high_quality.mp4 Biomarker-based phase II trial designs https://cast.itunes.uni-muenchen.de/clips/tu6Od8OD2k/vod/high_quality.mp4 ISCB 2013 ISCB 2013 Thu, 29 Aug 2013 07:49:29 +0000 Marc Buyse, IDDI, Belgium ISCB 2013 no 00:22:23 21 https://cast.itunes.uni-muenchen.de/clips/tu6Od8OD2k/vod/high_quality.mp4 Gene signatures as treatment modifiers in clinical trial https://cast.itunes.uni-muenchen.de/clips/zyC77Qm0bz/vod/high_quality.mp4 ISCB 2013 ISCB 2013 Thu, 29 Aug 2013 07:49:49 +0000 Stefan Michiels, Institut Gustave Roussy, France ISCB 2013 no 00:24:44 22 https://cast.itunes.uni-muenchen.de/clips/zyC77Qm0bz/vod/high_quality.mp4